Fibrobiologics Inc (FBLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 12-2021 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 0 | 0 | 2,266 | 407 |
| Receivables | 0 | 0 | 300 | 0 |
| Other current assets | 0 | 0 | 59 | 61 |
| TOTAL | $0 | $0 | $2,625 | $468 |
| Non-Current Assets | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $0 | $0 | $4,824 | $468 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 0 | 0 | 758 | 233 |
| Other current liabilities | 0 | 0 | 538 | 0 |
| TOTAL | $0 | $0 | $7,073 | $1,758 |
| Non-Current Liabilities | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $0 | $0 | $8,820 | $1,758 |
| Shareholders' Equity | ||||
| Common Shares | 0 | 0 | 1 | 0 |
| Retained earnings | 0 | 0 | -7,872 | -2,751 |
| Other shareholders' equity | 0 | 0 | 1,461 | 1,461 |
| TOTAL | $0 | $0 | $-3,996 | $-1,290 |
| Total Liabilities And Equity | $0 | $0 | $4,824 | $468 |